329 related articles for article (PubMed ID: 25793203)
1. Binding of carbonic anhydrase IX to 45S rDNA genes is prevented by exportin-1 in hypoxic cells.
Sasso E; Vitale M; Monteleone F; Boffo FL; Santoriello M; Sarnataro D; Garbi C; Sabatella M; Crifò B; Paolella LA; Minopoli G; Winum JY; Zambrano N
Biomed Res Int; 2015; 2015():674920. PubMed ID: 25793203
[TBL] [Abstract][Full Text] [Related]
2. Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells.
Buanne P; Renzone G; Monteleone F; Vitale M; Monti SM; Sandomenico A; Garbi C; Montanaro D; Accardo M; Troncone G; Zatovicova M; Csaderova L; Supuran CT; Pastorekova S; Scaloni A; De Simone G; Zambrano N
J Proteome Res; 2013 Jan; 12(1):282-92. PubMed ID: 23181366
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
4. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
[TBL] [Abstract][Full Text] [Related]
5. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
[TBL] [Abstract][Full Text] [Related]
7. Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells.
Radvak P; Repic M; Svastova E; Takacova M; Csaderova L; Strnad H; Pastorek J; Pastorekova S; Kopacek J
Oncol Rep; 2013 Mar; 29(3):1147-53. PubMed ID: 23291973
[TBL] [Abstract][Full Text] [Related]
8. Role of aryl hydrocarbon receptor in modulation of the expression of the hypoxia marker carbonic anhydrase IX.
Takacova M; Holotnakova T; Vondracek J; Machala M; Pencikova K; Gradin K; Poellinger L; Pastorek J; Pastorekova S; Kopacek J
Biochem J; 2009 Apr; 419(2):419-25. PubMed ID: 19154183
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
[TBL] [Abstract][Full Text] [Related]
11. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells.
Rafajová M; Zatovicová M; Kettmann R; Pastorek J; Pastoreková S
Int J Oncol; 2004 Apr; 24(4):995-1004. PubMed ID: 15010840
[TBL] [Abstract][Full Text] [Related]
12. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.
Vordermark D; Kaffer A; Riedl S; Katzer A; Flentje M
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1197-207. PubMed ID: 15752902
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D
Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype.
Barathova M; Takacova M; Holotnakova T; Gibadulinova A; Ohradanova A; Zatovicova M; Hulikova A; Kopacek J; Parkkila S; Supuran CT; Pastorekova S; Pastorek J
Br J Cancer; 2008 Jan; 98(1):129-36. PubMed ID: 18026188
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
17. Expression of carbonic anhydrase IX in craniopharyngiomas.
Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
[TBL] [Abstract][Full Text] [Related]
18. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
Bao B; Groves K; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Rajopadhye M; Peterson JD
PLoS One; 2012; 7(11):e50860. PubMed ID: 23226406
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence- and spin-labeled carbonic anhydrase inhibitors.
Cecchi A; Supuran CT
Curr Pharm Des; 2008; 14(7):699-707. PubMed ID: 18336316
[TBL] [Abstract][Full Text] [Related]
20. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
